Chu P - Search Results

1

Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study.

Altman AD, Thompson J, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: chu p. J Obstet Gynaecol Can. 2012 Jul;34(7):664-72. doi: 10.1016/s1701-2163(16)35320-8. J Obstet Gynaecol Can. 2012. PMID: 22742486

2

Malignant chest wall endometriosis: a case report and literature review.

Agrawal A, Nation J, Ghatage P, Chu P, Ross S, Magliocco A. Agrawal A, et al. Among authors: chu p. J Obstet Gynaecol Can. 2009 Jun;31(6):538-541. doi: 10.1016/S1701-2163(16)34217-7. J Obstet Gynaecol Can. 2009. PMID: 19646320

3

Cutaneous metastatic disease in cervical cancer: a case report.

Agrawal A, Yau A, Magliocco A, Chu P. Agrawal A, et al. Among authors: chu p. J Obstet Gynaecol Can. 2010 May;32(5):467-472. doi: 10.1016/S1701-2163(16)34501-7. J Obstet Gynaecol Can. 2010. PMID: 20500956

4

Intraperitoneal chemotherapy for advanced ovarian and peritoneal cancers in patients following interval debulking surgery or primary cytoreductive surgery: Tom Baker Cancer Centre experience from 2006 to 2009.

Nelson G, Lucero CA, Chu P, Nation J, Ghatage P. Nelson G, et al. Among authors: chu p. J Obstet Gynaecol Can. 2010 Mar;32(3):263-9. doi: 10.1016/s1701-2163(16)34453-x. J Obstet Gynaecol Can. 2010. PMID: 20500971

5

Vacuum assisted wound closures in gynaecologic surgery.

Altman AD, Nelson G, Nation J, Chu P, Ghatage P. Altman AD, et al. Among authors: chu p. J Obstet Gynaecol Can. 2011 Oct;33(10):1031-1037. doi: 10.1016/S1701-2163(16)35052-6. J Obstet Gynaecol Can. 2011. PMID: 22014780 Review.

6

Optimal debulking targets in women with advanced stage ovarian cancer: a retrospective study of immediate versus interval debulking surgery.

Altman AD, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: chu p. J Obstet Gynaecol Can. 2012 Jun;34(6):558-566. doi: 10.1016/S1701-2163(16)35272-0. J Obstet Gynaecol Can. 2012. PMID: 22673172

7

Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.

Altman AD, Nelson GS, Chu P, Nation J, Ghatage P. Altman AD, et al. Among authors: chu p. Int J Gynecol Cancer. 2012 Jul;22(6):1006-12. doi: 10.1097/IGC.0b013e31825b7de8. Int J Gynecol Cancer. 2012. PMID: 22740004 Review.

8

Architectural patterns of ovarian/pelvic high-grade serous carcinoma.

Bromley AB, Altman AD, Chu P, Nation JG, Nelson GS, Ghatage P, Kalloger SE, Han G, Köbel M. Bromley AB, et al. Among authors: chu p. Int J Gynecol Pathol. 2012 Sep;31(5):397-404. doi: 10.1097/PGP.0b013e31824c2372. Int J Gynecol Pathol. 2012. PMID: 22833078

9

Quantification of ER/PR expression in ovarian low-grade serous carcinoma.

Escobar J, Klimowicz AC, Dean M, Chu P, Nation JG, Nelson GS, Ghatage P, Kalloger SE, Köbel M. Escobar J, et al. Among authors: chu p. Gynecol Oncol. 2013 Feb;128(2):371-6. doi: 10.1016/j.ygyno.2012.10.013. Epub 2012 Oct 24. Gynecol Oncol. 2013. PMID: 23103384

10

Dose-dense paclitaxel with carboplatin for advanced ovarian cancer: a feasible treatment alternative.

Glaze S, Teitelbaum L, Chu P, Ghatage P, Nation J, Nelson G. Glaze S, et al. Among authors: chu p. J Obstet Gynaecol Can. 2013 Jan;35(1):61-7. doi: 10.1016/s1701-2163(15)31050-1. J Obstet Gynaecol Can. 2013. PMID: 23343799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,029 results

Search Page

Filters